Prosecutors seeking 15 years behind bars for Theranos CEO Elizabeth Holmes
Federal prosecutors are recommending a sentence of 15 years in prison for disgraced Theranos founder Elizabeth Holmes, Reuters reported Friday.
Holmes, 38, was found guilty this past January of defrauding investors about the merits of Theranos' blood-testing machines. She is facing a maximum of 20 years in prison, though experts predicted her actual sentence would likely be shorter.
In addition to the recommended sentence, U.S. attorneys said Holmes should be forced to pay $800 million in restitution to investors, per Reuters.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Holmes is scheduled to be sentenced next week, and her time in prison will be the final domino to fall in one of the largest investment fraud schemes in American history, as well as one of the most notable falls from grace in tech history. Forbes had at one point named Holmes the youngest self-made female billionaire in the country, and Theranos had an estimated valuation of $9 billion.
However, an investigation by The Wall Street Journal soon revealed that Holmes and other top officials at Theranos had lied to investors about the accuracy and capabilities of their blood-testing machines. As the investigation grew to involve the federal government, Theranos' value soon plunged to zero, and the SEC soon charged Holmes with "massive fraud" related to her running of the company.
According to reports from The Associated Press and Bloomberg, Holmes is seeking an 18-month house arrest sentence in lieu of prison time. However, it was noted that, given the scope of her crimes, this request was unlikely to be granted.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other Hollywood news. Justin has also freelanced for outlets including Collider and United Press International.
-
What can Elon Musk's cost-cutting task force actually cut?
Talking Points A $2 trillion goal. And big obstacles in the way.
By Joel Mathis, The Week US Published
-
Her Lotus Year: Paul French's new biography sets lurid rumours straight
The Week Recommends Wallis Simpson's year in China is less scandalous, but 'more interesting' than previously thought
By The Week UK Published
-
Today's political cartoons - November 21, 2024
Cartoons Thursday's cartoons - wild cards, wild turkeys, and more
By The Week US Published
-
A growing iodine deficiency could bring back America's goiter
Under the Radar Ailment is back thanks to complacency, changing diets and a lack of public-health education
By Harriet Marsden, The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Flame retardants found in black plastics could have health consequences
Under the Radar Time to replace your kitchen tools
By Devika Rao, The Week US Published
-
The 'game-changing' treatment for schizophrenia
The Explainer US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects
By Harriet Marsden, The Week UK Published
-
The audio industry is working to tackle hearing aid stigma
The Explainer Only 1 in 5 people who could benefit from hearing aids use them, according to the Hearing Loss Association of America
By Justin Klawans, The Week US Published
-
Preeclampsia: The dangerous pregnancy condition is affecting more women
Under the Radar The condition of preeclampsia is on the rise and can be deadly if left untreated
By Devika Rao, The Week US Published